This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
Andeavor (ANDV) is trading at a forward PE (price-to-earnings) ratio of 14.4x, above its peer average of 13.9x. However, ANDV’s peers Delek US Holdings (DK) and PBF Energy (PBF) trade below the peer average with forward PEs of 10.6x and 12.4x, respectively.
PBF DK WNR VLO MPC
We saw in the previous part that refining stocks Andeavor (ANDV), Valero Energy (VLO), and Phillips 66 (PSX) surpassed their earnings estimates. However, Marathon Petroleum (MPC) missed its earnings estimate. In this article, we’ll look at additional details of their performances.
WNR VLO MPC
Hear that sucking sound? It’s more money flowing from your wallet and into your gas tank these days. Thanks to the growing global economy, demand for crude oil has surged in the wake of lower supplies. At the same time, demand for gasoline and other refined products has only increased. The end result is that gas prices have gone through the roof in a short amount of time.
SZK WNR SBUX GPS MPC ANDV
Andeavor (ANDV) posted its earnings on May 7. The company surpassed its earnings estimates for the quarter. Read, Andeavor’s 1Q18 Earnings Beat Estimates for more information. In this series, we’ll look at refining margins in more detail.
WNR VLO MPC
Good afternoon. This is Brad Troutman, Vice President of Investor Relations. And I'd like to thank you for joining our webcast covering progress of our strategic plans and our first quarter 2018 earnings. This webcast will be presented by Greg Goff, Chairman and CEO; and Steven Sterin, Executive Vice President and CFO.
WNRL WNR ANDV
It was a pretty great week for Midstream (AMEI +1.9%), but not so much for MLPs (-0.2%). The busiest week for 1Q earnings started exciting with a big merger of MLP sponsors and very strong 1Q results from big MLPs EPD and MPLX. As the week continued, however, MLP investor sentiment was dealt another blow with a surprise distribution cut from TCP and weak results from BPL.
TRP MPLX DCP CQP CNX.WI LNG WNR BWP MPC ANDV L KEX WES NS OKE PBA TRGP CNX
HOUSTON, May 01, 2018 (GLOBE NEWSWIRE) -- Gulf Island Fabrication, Inc. (“Gulf Island” or the “Company”) (NASDAQ:GIFI), announced today that, through its Fabrication Division, it has delivered four modules representing 9,800 tons of fabricated steel and assembled components for an ethylene plant in Lake Charles, Louisiana. Gulf Island was awarded the project by CB&I’s Oil & Gas EPC group to assemble their highly selective SRT® cracking heater modules (one of three is shown in-transit below) and a secondary transfer-line exchanger module.
Welcome to the Quarterly Earnings Conference Call. [Operator Instructions] I would like to inform all parties that today's conference is being recorded. If you have any objections, you may disconnect at this time.
KMI WNR KMR KMRFZ CVB
10h - Asif
Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...
11h - Asif
Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...
11h - Asif
General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...
as of ET